arrow
M

Michael J. Smith

Duke University School of Medicine
H指数:35
被引数:6,859

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical immunization safety assessment (CISA) project: COVID-19 vaccine consultations and case reviews

临床免疫接种安全性评估(CISA)项目:COVID-19疫苗咨询和病例审查

Vaccine
IF3.5
2025-09-270
OAAI
A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18-45 years of age

一项关于两种四价季节性流感疫苗(Fluzone®或Flublok®)在18-45岁健康成年人中,单独使用或与两种佐剂(AF03或Advax-CpG55.2)联合使用时的安全性、反应原性和免疫原性的I期研究

VACCINE
IF3.5
2025-04-010
PRE
Opportunistic dried blood spot sampling validates and optimizes a pediatric population pharmacokinetic model of metronidazole
2024-04-031
OA
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults

一项2期临床试验,用于评估在健康美国成年人中使用和不使用AS03佐剂的2013年和2017 A(H7N9) 灭活流感病毒疫苗的安全性,反应原性和免疫原性

2024-03-274
PRE
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
2023-08-2819
OAAI
School Masking Policies and Secondary SARS-CoV-2 Transmission
2022-05-2032
OA